Ahren Innovation Capital focuses on transformational companies at the intersection of deep technology and deep science, with key domains including Brain & AI, Genetics & Platform Technologies, Space & Robotics, and Efficient Energy. Their strategy involves providing patient and active capital to exceptional founders and teams across all stages, from pre-seed to pre-IPO, to help them create or penetrate massive markets.
30% of their portfolio is in AI. Deal activity increased 100% year-over-year (2 deals in the last 12 months). Their most common stage is series-b (40% of deals). Average disclosed round size is $108.3M (across 10 rounds with reported amounts).
Portfolio
10
Fund Size
$253M
Top Stage
Series B
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
10 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| CCassidy Bio | Seed | $8M | Nov 2025 |
 Bitfount | Series A | $6.8M | Jul 2025 |
 Heirloom Carbon | Series B | $150M | Dec 2024 |
 Sunfire | Series E | $500M | Mar 2024 |
 AI21 Labs | Series B | $64M | Jul 2022 |
| CCambridge Epigenetix | Series D | $88M | Nov 2021 |
 New Culture | Series A | $25M | Nov 2021 |
 Zoe | Series B | $53M | May 2021 |
 Graphcore | Series D | $150M | Feb 2020 |
 Zapata Computing | Series B | $38M | — |
Top Co-Investors
Robert Bosch Venture Capital2 shared
Temasek Holdings1 shared
Third Point Ventures1 shared
GV (Google Ventures)1 shared
Science1 shared
Sequoia Capital1 shared
Accomplice1 shared
Daphni1 shared
Parkwalk Advisors1 shared
Foresight Ventures1 shared
Portfolio Ventures1 shared
Mayfield Fund1 shared
ADM1 shared
Future Fund1 shared
SOSV1 shared
S2G Ventures1 shared
CPT Capital1 shared
CJ CheilJedang1 shared
Baillie Gifford1 shared
M&G Investments1 shared
Last updated: 12 April 2026